Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹457 Cr₹489 Cr₹90 Cr₹94 Cr₹80 Cr

What is the latest Total Non-Current Liabilities ratio of GLAND PHARMA ?

The latest Total Non-Current Liabilities ratio of GLAND PHARMA is ₹457 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹457 Cr
Mar2024₹489 Cr
Mar2023₹90 Cr
Mar2022₹94 Cr
Mar2021₹80 Cr

How is Total Non-Current Liabilities of GLAND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹457 Cr
-6.41
Mar2024 ₹489 Cr
444.83
Mar2023 ₹90 Cr
-4.57
Mar2022 ₹94 Cr
17.01
Mar2021 ₹80 Cr -

Compare Total Non-Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,698.8 Cr -1% -1.8% -8.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,073.0 Cr -0% -3.2% -5% Stock Analytics
DIVIS LABORATORIES ₹175,657.0 Cr 4% 5.2% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,121.0 Cr 2.4% 4.5% 18.3% Stock Analytics
CIPLA ₹118,431.0 Cr -3.5% -1.5% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,944.0 Cr -3.2% -3.3% -10.6% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1%

-1.8%

-8.2%

SENSEX

-2.6%

-1.3%

7.2%


You may also like the below Video Courses